GLP-1 Drugs and Parkinson's Disease Neuroprotection
GLP-1 drugs show promise for Parkinson's through multiple protective pathways in dopamine neurons.
Estelle Vance
Contributing Editor
Estelle Vance
Estelle Vance is a contributing editor at glpletter covering emerging glp-1 indications. Based in Copenhagen, Estelle has written for glpletter since 2015.
1 story · Copenhagen